Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
    • Internet & Telecom
  • Toggle search form
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Plant 5 Revenue Contribution · US Plant Acquisition · Plant 6 Groundbreaking / 2026-04-23 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2025 Earnings Presentation / 2025-07-31 IR Room
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Long-Term Contracts · HBM4 / 2026-01-14 Research
  • [Research] Samsung SDI (006400) – Hanwha Investment & Securities | Delayed EV Recovery · ESS Highlights as Sole Driver · Target Price Cut / 2026-01-07 Research
  • [Research] LIG D&A (079550) – Hana Securities | 4Q25 Miss · Solid Order Backlog · Medium-to-Long-term Fundamentals / 2026-02-19 Research
  • [Research] LIG D&A (079550) – Shinhan Securities | 4Q25 One-off Shock · KRW 26.2T Backlog · Long-term Structural Growth / 2026-02-20 Research
  • [Research] KEPCO (015760 / KEP) – Eugene Investment & Securities | Nuclear Normalization · US-Korea Nuclear Cooperation · Power Market Reform / 2026-05-14 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Agentic AI · Server CPU · LPDDR / 2026-04-28 Research

[Research] KEPCO (015760 / KEP) – Daishin Securities | Oil & LNG Price Surges · Tariff Uncertainty · Overseas Nuclear Momentum / 2026-05-14

Posted on 5월 14, 20268월 25, 2026 By ksb220805@gmail.com

Market: KOSPI (015760)

Brokerage : Daishin Securities

Analyst : Min-ho Hur

Investment Rating : BUY (Maintained)

Target Price : KRW 62,000 (Downgraded)

Core Momentum : While near-term earnings momentum weakens due to soaring oil/LNG costs and tariff uncertainties, focus shifts toward overseas nuclear expansion catalysts driven by the Special Act on US Investment.

📊 1. [Valuation & Key Financial Metrics]

  • Rating & Target Price: BUY (Maintained), 6-Month Target Price lowered by 23% to KRW 62,000 (Target P/B lowered from 0.87x to 0.69x).
  • Target Price Valuation Rationale: Incorporates cost increases from surging LNG prices from 3Q26 and uncertainty over the timing of offsetting power tariff hikes (material tariff adjustments aimed at balance sheet recovery are not projected until 4Q27).
  • Key Financial Results & Estimates:
    • 1Q26 Results: Revenue KRW 24.40 Trillion (+0.7% YoY, +3.0% QoQ), Operating Profit KRW 3.78 Trillion (+0.8% YoY, +94.1% QoQ, missing consensus of KRW 4.24 Trillion), Net Profit KRW 2.45 Trillion (+5.1% YoY).
    • 2Q26 Estimates: Revenue KRW 21.94 Trillion (0.0% YoY, -10.1% QoQ), Operating Profit KRW 2.08 Trillion (-2.5% YoY, -45.0% QoQ), Net Profit KRW 1.13 Trillion (-0.8% YoY, -53.9% QoQ).
    • 2026 Full-Year Forecast: Operating Profit projected at KRW 8.91 Trillion (-34% YoY).

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Review & Short-Term Cost Environment:
    • 1Q operating profit missed consensus due to reduced sales volume in high-margin industrial power (-2.4%), higher KRW/USD exchange rates, and lower nuclear utilization.
    • Implementation of seasonal time-of-use industrial tariffs in mid-April resulted in an effective -1.7% tariff reduction.
    • Concerns persist over Middle East energy infrastructure restoration timelines following the US-Iran conflict, with significant LNG import cost spikes expected from 3Q26.
    • Due to government inflation-control measures, power tariff hikes remain constrained during commodity spikes, postponing tariff relief until energy prices stabilize.
  • Expansion into Overseas Nuclear Markets (From Late June):
    • Momentum from US-Korea investment cooperation expected following the enactment of the Special Act on US Investment and the launch of the Korea-US Strategic Investment Corporation (tentative) on June 18.
    • Out of a total $350 Billion investment framework, $200 Billion (up to $20 Billion annually) is allocated to Korean government-led equity investments in nuclear (SMRs, large-scale reactors), power grids, AI data centers, and critical minerals.
    • Leveraging EPC and O&M track records, KEPCO Group is positioned for key roles in US reactor buildouts and potential direct export of Korean reactor models.
    • Post-2027 export pipeline includes project discussions across Vietnam, Türkiye, Saudi Arabia, UAE Phase 2, and Czech Phase 2.

📝 Editor’s Comment (Perspective)

The analyst views KEPCO as a utility navigating a transient earnings deceleration caused by commodity cost spikes and delayed tariff hikes, but one that is pivoting toward a valuation re-rating driven by the Special Act on US Investment and a broadening global nuclear export pipeline. The core perspective prioritizes long-term overseas expansion—specifically bilateral US energy partnerships and pipeline projects across emerging markets—over near-term domestic margin fluctuations.

To evaluate whether this investment thesis unfolds as anticipated, key tracking points include the company’s margin resilience against 3Q LNG price increases, the concrete progress of equity investments and contracts via the Korea-US Strategic Investment Corporation post-June 18, and tangible milestones in overseas nuclear bids across Vietnam and the Czech Republic. These developments can be verified through KEPCO’s quarterly financial disclosures, DART filings, and official government releases regarding overseas energy cooperation.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Energy

글 탐색

Previous Post: [Research] KEPCO (015760 / KEP) – Hana Securities | Annual Earnings Peak · Cost Push Pressure · Prudent Stance / 2026-05-14
Next Post: [Research] KEPCO (015760 / KEP) – Eugene Investment & Securities | Nuclear Normalization · US-Korea Nuclear Cooperation · Power Market Reform / 2026-05-14

Related Posts

  • [Research] Hanwha Ocean (042660) – Daishin | Merchant Vessel Margin · FX Impact · US Navy Logistics Synergy / 2026-07-29 Research
  • [Research] LIG D&A (079550) – iM Securities | Export Pipeline · CapEx & Hiring Expansion · Global Air Defense Growth / 2026-08-07 Research
  • [Research] Samsung Electronics (005930) – Hyundai Motor Securities | HBM4 Share · AIDC Capex · DRAM ASP / 2026-07-31 Research
  • [Research] Samsung SDI (006400) – Kiwoom Securities | Near-Term Sluggishness but Intact Momentum · 4Q26 Turnaround · Solid-State Pipeline / 2026-02-03 Research
  • [Research] Samsung Electronics (005930) – Yuanta | 2Q26 OP KRW 86.8T · Memory Price Momentum · Target Price Upgrade / 2026-04-30 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Server CPU Demand · HBM Diversification · HBM4 / 2026-05-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | 4Q25 Review · MLCC Shortage · FC-BGA Full Capa / 2026-01-26 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | Profit Turnaround · ESS Margin Support · North America LFP Ramp-up / 2026-07-20 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2025 Earnings Presentation / 2026-01-23 IR Room
  • [Research] Samsung Electronics (005930) – Mirae Asset | Foundry Value Upgrade · Advanced Node Wins · HBM Revenue Surge / 2026-05-07 Research
  • [Research] Samsung Electronics (005930) – Shinhan | Supply-Demand Imbalance · High-Value Mix Expansion · Target PBR Upgrade / 2026-05-21 Research
  • [IR] Samsung Electronics (005930) – Q3 2025 Earnings Presentation / 2025-10-30 IR Room
  • [Research] SK hynix (000660 / SKHY) – Daishin | Legacy Memory Pricing · LTA · ADR / 2026-02-23 Research
  • [Research] ABL Bio (298380) – DS Investment & Securities | ABL001 Data Failure · Grabody Platforms · Intrinsic Value / 2026-04-28 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme